FIELD: medicine.
SUBSTANCE: invention relates to oncology and ophthalmology, and can be used to predict survival rate after enucleation in uveal melanoma of ciliary and/or post-equatorial choroidal localization. Presence or absence of ophthalmic hypertension, involvement of the ciliary body and/or post-equatorial choroid into the tumor process, weak staining using an immunohistochemical reaction with a FLK receptor marker and/or intense staining with a VEGF marker of endothelial cells of tumor vessels and predicting survival in months by a given formula.
EFFECT: method provides higher accuracy of prediction of survival rate after enucleation of uveal melanoma of ciliary and/or post-equatorial choroidal localization due to assessment of set of the most significant parameters.
1 cl, 2 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF SURVIVAL RATE AFTER ENUCLEATION WITH UVEAL MELANOMA DEVELOPED TO EQUATOR | 2024 |
|
RU2822319C1 |
| METHOD FOR DETERMINING TIME OF FIRST METASTASIS AFTER ENUCLEATION IN UVEAL MELANOMA | 2024 |
|
RU2827578C1 |
| METHOD OF PREDICTION OF CLINICAL COURSE OF UVEA MELANOMA BASED ON APOPTHOSIS MARKER Bax | 2002 |
|
RU2208790C1 |
| METHOD PREDICTING CLINICAL COURSE OF UVEA MELANOMA BASED ON APOPTHOSIS MARKER p53 | 2002 |
|
RU2208789C1 |
| METHOD OF SIMULTANEOUS VERIFICATION AND PREDICTION OF COURSE OF UVEAL MELANOMA | 2006 |
|
RU2337362C1 |
| METHOD OF SIMULTANEOUS VERIFICATION OF UVEAL MELANOMA COURSE FORECAST | 2006 |
|
RU2327420C1 |
| METHOD FOR PREDICTING CLINICAL FLOW OF UVEAL MELANOMA | 2001 |
|
RU2193200C1 |
| METHOD FOR PREDICTING METASTASES OF UVEAL MELANOMA BASED UPON APOPTOSIS MARKERS BAX AND BCL-2 | 2003 |
|
RU2242766C1 |
| METHOD FOR PREDICTING UVEAL MELANOMA METASTASIS FORMATION ON THE BASIS OF BAX AND KI-67 MARKERS | 2003 |
|
RU2240560C1 |
| METHOD FOR PREDICTING CLINICAL COURSE OF UVEAL MELANOMA DEVELOPMENT | 2001 |
|
RU2197731C2 |
